Financials

News Ideas Discussions Technicals Forecast Seasonals Bonds

CHRS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Coherus BioSciences, Inc.

Total assets of CHRS for Q3 24 is 505.00 M USD, 25.17% less than the previous Q2 24. And total liabilities decreased by 21.87% in Q3 24 to 592.97 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—